Sales & Marketing News | pharmaphorum

News

SGLT latecomer Lexicon gets heart failure okay

Lexicon Pharma tried and failed to get FDA approval for its SGLT inhibitor sotagliflozin for diabetes, but it has finally got the drug over the finish line – for a differe

News

EU approval for Novartis’ sickle cell drug set to be pulled

Novartis has said it is “disappointed” that the EMA’s Human Medicines Committee has recommended revoking the conditional EU approval for sickle cell disease (SCD) therapy

News

Icahn pick displaces chair John Thompson on Illumina board

Illumina shareholders have voted to oust the company’s chairman John Thompson, although chief executive Francis DeSouza has emerged from the annual meeting unscathed.

News

CMS plan would shine light on Medicaid drug pricing

A proposal by the US Department of Health and Human Services (HHS) would expose the actual costs of drugs covered by Medicaid, and hold manufacturers to account for the am

News

Bankruptcy court clears $397m Purdue consumer health sale

A judge in the US has approved the sale of Purdue Pharma’s consumer health business Avrio, part of the bankruptcy proceedings related to the drugmaker’s proposed $10 billi

News

Innoviva gets FDA nod for pneumonia antibiotic

The FDA has given a green light to Innoviva’s antibiotic combination Xacduro, which becomes the first drug specifically approved for pneumonia caused by hard-to-treat bact

SGLT latecomer Lexicon gets heart failure okay

EU approval for Novartis’ sickle cell drug set to be pulled

Icahn pick displaces chair John Thompson on Illumina board

CMS plan would shine light on Medicaid drug pricing

Bankruptcy court clears $397m Purdue consumer health sale

Innoviva gets FDA nod for pneumonia antibiotic

Sanofi drops two more programmes in R&D clear-out

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks